7DNY

HT9: coproporphyrin III

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8AT8_HT9_A_406	78%	48%	0.096	0.939	0.9	1.11	1	2	0	0	100%	1
8OMM_HT9_A_404	67%	49%	0.133	0.943	0.83	1.13	-	1	1	0	100%	1
8OFL_HT9_A_403	63%	47%	0.119	0.915	0.82	1.22	-	2	2	0	100%	1
9F0F_HT9_A_401	59%	51%	0.145	0.929	0.83	1.05	-	-	1	0	100%	1
8BBV_HT9_A_404	56%	52%	0.16	0.932	0.83	1.02	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.